Does NICE influence the adoption and uptake of generics in the UK?

14 February 2021 - The aim of this paper is to examine generic competition in the UK, with a special focus ...

Read more →

FDA’s generic drug program in 2020 helped ensure availability of high quality, affordable drugs amid COVID-19

11 February 2021 - Generic drugs play a vital role in facilitating access to lifesaving medicines for Americans and remain a ...

Read more →

Billionaire Mark Cuban wants to lower drug prices with generics startup

15 January 2021 - Billionaire Mark Cuban is mad about the high cost of prescription drugs in the United States, ...

Read more →

Amneal launches generic abiraterone acetate 500 mg tablets following ANDA approval by FDA

8 January 2021 - Amneal Pharmaceuticals announced that it has received approval of an additional strength of 500 mg to its ...

Read more →

FDA approves first generic of drug used to treat severe hypoglycaemia

28 December 2020 - Today, the U.S. FDA approved the first generic of glucagon for injection USP, 1 mg/vial packaged in ...

Read more →

Hikma launches generic Advair Diskus following FDA approval

17 December 2020 - Hikma Pharmaceuticals announces it has received FDA approval for and launched its generic version of GlaxoSmithKline’s ...

Read more →

FDA updates list of off-patent, off-exclusivity drugs without an approved generic

17 December 2020 - Today, the U.S. FDA published an update to the “List of Off-Patent, Off-Exclusivity Drugs without an Approved ...

Read more →

GPs tell inquest they were unaware PHARMAC changed their patients' epilepsy drugs

30 November 2020 - Two GPs caring for patients who died after switching brands of an epilepsy drug say they were ...

Read more →

Sudden epilepsy deaths: grieving mum speaks out ahead of coronial inquest

28 November 2020 - Michelle Townes believes her 31-year-old son died because the brand of his Government funded drug was switched.  ...

Read more →

Drug change not ruled out as factor in epilepsy death, neurologist's report says

29 November 2020 - The first official recognition that changing brands of epilepsy drugs may have been a factor in at ...

Read more →

A CDER study of factors that may predict the likelihood of generic drug marketing applications

28 October 2020 - The investigators compiled proprietary data related to abbreviated new drug applications and other internal or public ...

Read more →

FDA approves fewer generics in FY2020, ending record streak

21 October 2020 - After four straight years of posting record numbers of abbreviated new drug application approvals, the US ...

Read more →

Glenmark Pharmaceuticals receives ANDA approval for sirolimus 0.5 mg, 1 mg and 2 mg tablets

19 October 2020 - Glenmark Pharmaceuticals has received final approval by the United States FDA for sirolimus 0.5 mg, 1 mg ...

Read more →

Hikma updates on ANDA for generic Advair Diskus

22 September 2020 - Hikma Pharmaceuticals announces that it has received a minor complete response letter from the US FDA ...

Read more →

California may be the first state to develop its own generic drugs

1 September 2020 - California is poised to become the first state to develop its own line of generic drugs, ...

Read more →